New triple screen test for down syndrome: Combined urine analytes and serum AFP

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 7, Issue 3, 1998, Pages 111-114

  Bahado Singh, Ray O ^a   Oz, Utku ^a   Kovanci, Ertug ^a   Cermik, Dilek ^a   Flores, Divinia ^a   Copel, Joshua ^a   Mahoney, Maurice ^a   Cole, Laurence ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AFP; Down syndrome; Estriol; Urine core fragment

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL;

AMNIOCENTESIS; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; HUMAN; MALE; MATERNAL AGE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; URINALYSIS;

ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; ESTRIOL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0031783095     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.3109/14767059809020424     Document Type: Article

References (14)

1. Cuckle HS, Iles RK, Sehmi IH, Chard T, Oakey RE, Davies S, Ind T: Urinary multiple marker screening for Down's syndrome. Prenat Diagn 15:745-751, 1995.
2. Canick JA, Kellner LH, Sailer DN, Jr, Palomaki GE, Walker RP, Osathanondh R: Second trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy. Prenat Diagn 15:679-682, 1995.
3. Kellner LH, Canick JA, Palomaki GE, Saller DN, Lambert-Messerlian GM, Neuer M, Osathanondh R, Bombard AT: Urinary markers: A new approach to screening for Down syndrome in the second trimester. Am J Hum Genet 59:A41:207, 1996.
4. Isozaki T, Palomaki GE, Bahado-Singh RO, Cole LA: Screening for Down syndrome pregnancy using β-core fragment: Prospective study. Prenat Diagn 17, 407-413, 1997.
5. Cole L, Acuna E, Isozaki T, Palomaki G, Bahado-Singh R, Mahoney M: Combining β-core fragment and total estriol measurements to test for Down syndrome pregnancies. Prenat Diagn 17:1125-1133, 1997.
6. Haddow JE, Palomaki GE: Prenatal screening for Down syndrome. In: Simpson JL, Elias, S (eds): "Essentials of Prenatal Diagnosis." New York Churchhill Livingstone, pp 185-220, 1993.
7. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al.: Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 297:883-687, 1988.
8. Palomaki GE, Haddow JE: Maternal serum a-fetoprotein, age, and Down syndrome risk. Am J Obstet Gynecol 156:460-463, 1987.
9. Cole LA, Kardana A, Andrade-Gordon P, Gawinowicz MA, Morris JC, Bergert ER, O'Connor J, Birken S: The heterogeneity of hCG:III. The occurrence, biological and immunological activities of nicked hCG. Endocrinology 129:1559-1567, 1991.
10. Cole LA, Kardana A, Park S-Y, Braunstein GD: The deactivation of hCG by nicking and dissociation. J Clin Endocrinol Metab 76:704-710, 1993.
11. Wald NJ, Cuckle HS, Densem JW: Maternal serum unconjugated estriol as an antenatal screening test for Down syndrome. Br J Obstet Gynecol 95:334-335, 1986.
12. Cuckle HS, Iles RK, Chard T: Urinary β-core human chorionic gonadotropin: A new approach to Down's syndrome screening. Prenat Diagn 14:953-958, 1994.
13. Spencer K, Aitken DA, Macri JN, Buchanan PD: Urine free beta hCG and beta core in pregnancies affected by Down's syndrome. Prenat Diagn 16:605-613, 1996.
14. Cole LA: The stability of hCG free β- subunit and β-core fragment in urine. Prenat Diagn 17:185-189, 1997.